Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1117 ARTÍCULOS , VIENDO DEL 376 AL 390

Circular RNAs, miRNAs, and Exosomes: Their Roles and Importance in Amyloid-Beta and Tau Pathologies in Alzheimer's Disease

Pala M, Yilmaz SG.

Neural Plast. 2025 Apr 8;2025:9581369. doi: 10.1155/np/9581369. eCollection 2025.

Dynamics and role of covalently-closed circular RNAs in Alzheimer's disease: A review of experimental and bioinformatics studies

Zafarjafarzadeh N, Feridouni E, Sobhani-Moghaddam S, Amini J, Mollazadeh S, Ataei R, Ghomi H, Beyer C, Sanadgol N.

Neurobiol Aging. 2025 Jul;151:54-69. doi: 10.1016/j.neurobiolaging.2025.04.002. Epub 2025 Apr 11.

Targeting of PP2 A/GSK3β/PTEN Axis in Alzheimer Disease: The Mooting Evidence, Divine, and Devil

Alqahtani SM, Al-Kuraishy HM, Al-Gareeb AI, Abdel-Fattah MM, Alsaiari AA, Alruwaili M, Papadakis M, Alexiou A, Batiha GE.

Cell Mol Neurobiol. 2025 Apr 18;45(1):36. doi: 10.1007/s10571-025-01554-0.

Ferroptosis in Alzheimer's Disease: The Regulatory Role of Glial Cells

Xu J, Shen R, Qian M, Zhou Z, Xie B, Jiang Y, Yu Y, Dong W.

J Integr Neurosci. 2025 Apr 24;24(4):25845. doi: 10.31083/JIN25845.

Role of mGluR7 in Alzheimer's disease: pathophysiological insights and therapeutic approaches

Hunjan G, Aran KR.

Inflammopharmacology. 2025 Jun;33(6):2977-2995. doi: 10.1007/s10787-025-01765-3. Epub 2025 May 3.

Research progress of cell senescence in Alzheimer's disease: mechanisms and therapy

Cai J, Yang L, Xu Y, Wang L, Zhang M, Qiao J, Xu Q, Zhu H, Cai M.

Eur J Pharmacol. 2025 Sep 5;1002:177697. doi: 10.1016/j.ejphar.2025.177697. Epub 2025 May 2.

Recent Advances in Drug Development for Alzheimer's Disease: A Comprehensive Review

Xing H, Yue S, Qin R, Du X, Wu Y, Zhangsun D, Luo S.

Int J Mol Sci. 2025 Apr 21;26(8):3905. doi: 10.3390/ijms26083905.

Exploring the complex dimensions of Alzheimer's disease: The promising role of circular RNAs and their potential contributions

Harsij Z, Mehrabi Z, Davoudi N.

Gene. 2025 Aug 10;960:149549. doi: 10.1016/j.gene.2025.149549. Epub 2025 May 6.

Evaluation of Illumina and Oxford Nanopore Sequencing for the Study of DNA Methylation in Alzheimer's Disease and Frontotemporal Dementia

Pagano L, Lagrotteria D, Facconi A, Saraceno C, Longobardi A, Bellini S, Ingannato A, Bagnoli S, Ducci T, Mingrino A, Laganà V, Paparazzo E, Borroni B, Maletta R, Nacmias B, Montesanto A, Ghidoni R.

Int J Mol Sci. 2025 Apr 28;26(9):4198. doi: 10.3390/ijms26094198.

Implications of Mucin-Type O-Glycosylation in Alzheimer's Disease

Vela Navarro N, De Nadai Mundim G, Cudic M.

Molecules. 2025 Apr 24;30(9):1895. doi: 10.3390/molecules30091895.

RAGE-Mediated Effects of Formaldehyde in Alzheimer's Disease

Mikhailov IG, Mikhailova MS, Shuvaev AN, Gorina YV, Belozor OS.

Biochemistry (Mosc). 2025 Mar;90(3):334-348. doi: 10.1134/S0006297924604593.

Experimental modeling of Alzheimer's disease: Translational lessons from cross-taxon analyses

Yenkoyan KB, Kotova MM, Apukhtin KV, Galstyan DS, Amstislavskaya TG, Strekalova T, de Abreu MS, Chavushyan VA, Lim LW, Yang L, Rosemberg DD, Kalueff AV.

Alzheimers Dement. 2025 May;21(5):e70273. doi: 10.1002/alz.70273.

Inflammasome-Mediated Neuroinflammation: A Key Driver in Alzheimer's Disease Pathogenesis

McGroarty J, Salinas S, Evans H, Jimenez B, Tran V, Kadavakollu S, Vashist A, Atluri V.

Biomolecules. 2025 May 7;15(5):676. doi: 10.3390/biom15050676.

From genetic roots to recent advancements in gene therapy targeting amyloid beta in Alzheimer's disease

Peyvand P, Allami P, Rezaei N.

Rev Neurosci. 2025 May 30;36(8):825-848. doi: 10.1515/revneuro-2025-0025. Print 2025 Dec 17.

Alzheimer's disease pathogenesis: standing at the crossroad of lipid metabolism and immune response

Wang Z, Zhang L, Qin C.

Mol Neurodegener. 2025 Jun 4;20(1):67. doi: 10.1186/s13024-025-00857-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias